| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.33 | 0.05 |